Marker-free coselection for CRISPR-driven genome editing in human cells. - Wikidata - awgldk - TriplyDB

Marker-free coselection for CRISPR-driven genome editing in human cells.

Marker-free coselection for CRISPR-driven genome editing in human cells.

http://www.wikidata.org/entity/Q48266764

about

CRISPR-Cas12a-Assisted Recombineering in Bacteria.The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency.CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons.Optimized guide RNA structure for genome editing via Cas9.Beyond editing to writing large genomes.Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1.Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells.Double Selection Enhances the Efficiency of Target-AID and Cas9-Based Genome Editing in Yeast

P2860

Q41357802-F4AA4289-A540-49A6-98D1-8D7952445CE9 Q45870741-D07EB732-F30B-4216-9248-57184EC8C537 Q46257646-BAC6416D-2A46-48A8-BA34-5FB1FD7C15AD Q46309410-7C58562E-4F58-4D4F-B20F-DD2F1BF4318A Q47167833-3A7221C0-F6F8-4BFE-B8EA-8B48D882E3AD Q47324234-CAD0907B-0D13-4D0F-A8F0-7DF4337EC352 Q48158877-010BF92C-6CC1-4E1C-B424-C8959F384216 Q52430325-EDB84F7D-39CE-4755-82F5-AE37ED6C34D7 Q57036637-A5B2A736-134E-488B-929D-9DEB0C24E32F

P2860

Marker-free coselection for CRISPR-driven genome editing in human cells.

http://www.wikidata.org/entity/Q48266764

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Marker-free coselection for CRISPR-driven genome editing in human cells.

@en

Marker-free coselection for CRISPR-driven genome editing in human cells.

@nl

type

label

Marker-free coselection for CRISPR-driven genome editing in human cells.

@en

Marker-free coselection for CRISPR-driven genome editing in human cells.

@nl

prefLabel

Marker-free coselection for CRISPR-driven genome editing in human cells.

@en

Marker-free coselection for CRISPR-driven genome editing in human cells.

@nl

P1433

Q48266764-C282136F-D8D7-421C-AAE4-4774CBEDC2B2

P1476

Q48266764-D6980AB8-3DFB-45C0-B340-2C86031DBA4D

P2093

Q48266764-081465BC-8F36-4C28-A495-38B781FB3789

Q48266764-82808E93-3008-4FC6-8237-840E40D3D3EA

Q48266764-981BE7D1-F82F-41B5-BBD2-C906171A548F

Q48266764-C6AED359-7AC8-486C-B060-DBD8133C93CE

P2860

Q48266764-00C22121-A109-4F24-9E1C-7012F4BE788A

Q48266764-06A2257F-984E-4A58-8648-76D6AA2DFC6C

Q48266764-0F45EA09-46ED-4EBE-91C9-B9375DF8466F

Q48266764-12C3F88B-7DE7-4EF6-B064-CE77A7F35E4E

Q48266764-15B78D60-76E0-4352-997F-194C8A413E73

Q48266764-1CB09BE9-F2B9-4D6A-80AD-27C56F9446A1

Q48266764-2021C869-C54C-4F2F-91BE-69AB16BEC507

Q48266764-21E4B0AD-FE0B-4383-A7C2-42650DDF342E

Q48266764-24299371-A3EA-4F94-BA8F-2A71BE401C5A

Q48266764-265EA675-F154-44E7-AF2D-C66CF19CAF7F

P2888

Q48266764-87365B14-A019-4225-AD38-1ECE5F47C9E8

P304

Q48266764-AC3CAFF6-475C-4662-BCDA-190A27E7A4E0

P31

Q48266764-1C8985C1-6191-470A-9567-AC2630CCD40D

P356

Q48266764-2A17AAEF-3F5B-4DD7-B481-4E8383A10396

P433

Q48266764-DF23396E-0C13-448F-ACF6-833DE42632B3

P478

Q48266764-DBAE8B7F-F303-497D-B77B-D7CB932C57BC

P50

Q48266764-0C5A577E-176E-4015-9A39-D620A5E978D5

Q48266764-17138BBA-B334-45B7-AA88-EEF3AA09E5DD

Q48266764-3A1A2458-EB6E-4A8F-A349-AE3B540D3FD8

Q48266764-5B6124CE-3E5F-47DB-A44A-97773760702F

Q48266764-5E8A71D8-E5B1-49D6-896D-5EDDFE33E0EC

Q48266764-C6D4CBCE-7866-401F-BE01-564B8986E6DE

Q48266764-D54F4FE7-240B-4636-ACB2-8DE7D5F75385

Q48266764-E6244FA5-D561-4E69-903C-CD9CAE18A829

P577

Q48266764-D825F5BA-EFB8-43A2-A30B-BCB56471E4DA

P6179

Q48266764-7DF38427-4F0F-474D-B36B-043085D045EB

P698

Q48266764-D9E111CC-3F95-4E4D-A552-6339A920FF4F

P921

Q48266764-149664C8-454B-4580-8FED-31C766255173

P356

P1433

P1476

Marker-free coselection for CRISPR-driven genome editing in human cells.

@en

P2093

Dafni Synodinou

http://www.w3.org/2001/XMLSchema#string

Jayme Salsman

http://www.w3.org/2001/XMLSchema#string

Lusiné Bozoyan

http://www.w3.org/2001/XMLSchema#string

Mathieu Drouin

http://www.w3.org/2001/XMLSchema#string

P2860

RNA-guided human genome engineering via Cas9

Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system

Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain

Development and applications of CRISPR-Cas9 for genome engineering.

Genome editing with engineered zinc finger nucleases

Simple and efficient methods for enrichment and isolation of endonuclease modified cells

DNA targeting specificity of RNA-guided Cas9 nucleases

Genetic screens in human cells using the CRISPR-Cas9 system

A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans.

Gene conversion tracts from double-strand break repair in mammalian cells.

P2888

P304

615-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NMETH.4265

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Graham Dellaire

Daniel Steven Agudelo Pinto

Alexis Duringer

Caroline C Huard

Josée Laganière

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084863266

http://www.w3.org/2001/XMLSchema#string

P698

28417998

http://www.w3.org/2001/XMLSchema#string

P921